COPD Animal Models

Chronic Obstructive Pulmonary Disease, COPD lung functionCOPD (Chronic Obstructive Pulmonary Disease) is a disease state characterized by significant airflow limitation and lung tissue destruction. The main cause of COPD is exposure to cigarette smoke and environmental pollutants, such as fumes and fine particulate matter. Airflow limitation is one of the main pulmonary manifestations, caused by inflammation, loss of lung elasticity, lung tissue destruction and narrowing of the small airways. There are currently very few therapeutic treatments specific for COPD.

The two most common phenotypes of the disease are emphysema (parenchymal destruction) and chronic bronchitis (small-airway obstruction). The pathogenesis of emphysema and chronic bronchitis is very complex, with changes being controlled by susceptibility factors such as environmental exposures and host genetics. Animal models are key to advancing our knowledge and understanding of the pathogenesis of COPD in humans. To help develop new treatments, these animal models need to present clinical and pathologic features of the disease observed in humans.

Given COPD is an inherently heterogenous disease, a variety of animal models are utilized by researchers. Each model has its own advantages and limitations, helping elucidate different factors and pathways implicated in disease pathogenesis and progression. Further, as the natural course of disease progression in human can take years, animal models are essential; since disease induction, mimicking human pathogenesis, can be achieved in a much shorter timespan.

Common COPD Models

There are two well-established and widely used animal models of COPD: the elastase model and the cigarette-smoke (CS) exposure model. These are well established models and have provided key insights into the major mechanistic causes of COPD, including inflammation, oxidative stress, protease/antiprotease in-balance, alveolar cell apoptosis, early senescence and autophagy.

Elastase Model

One of the two most common models of COPD is the elastase-induced emphysema model. The elastase model originated from the clinical observation that alpha-1 antitrypsin deficient patients present with an early development of emphysema due to an abundance of elastase, a tissue degrading enzyme.

The emphysematous phenotype is usually achieved through single or repeated intratracheal instillation of elastase (commonly 1 week apart), with porcine pancreatic elastase (PPE) often being the elastase of choice. Following instillation, the enzyme is shown to be cleared from the lungs in 24h, while the airspace enlargement induced continues for 10 to 21 days.

Functional assessment of PPE-induced emphysema is usually performed 21 days after elastase administration. While changes can be detected at earlier time points (D10), measurements at D21 (3 weeks post instillation) have been shown to provide a more consistent increases in lung compliance (the ability of the lungs to stretch). In the elastase mouse model of emphysema, these changes can be perpetuated for up to 6 months.

The elastase model of emphysema is a useful approach when looking for a simple exposure protocol with rapid and significant lung injury development. However, other models are required to better represent the phenotype of the human disease.

Cigarette-Smoke (CS) exposure model

Cigarette-smoke (CS) exposure is the gold standard for COPD model development. In most cases, COPD is linked to CS exposure. As such, this model mimics human exposure more accurately, thus providing the highest relevance to the disease in humans. Further, COPD development in humans takes place over several years and elastase models do not replicate this slow progression.

CS exposure in animal is usually performed using one of two configurations, nose-only or whole-body exposure, with both resulting in emphysema. Systems used for this kind of exposure can usually be configured to deliver side-stream smoke, main-stream smoke or a mixture of both.

Animal Models for COPD

  • Whole-body CS exposure: For whole-body exposures, subjects are placed within a chamber and are free to move, minimizing subject stress. Subjects can also be supplied access to water and food, allowing for longer duration exposures. One consideration to keep in mind, in whole-body exposures the animals’ eyes and fur are exposed to CS leading to a risk of ingestion rather than inhalation.
  • Nose-only CS exposure: Nose-only configurations limit the exposure to the subject’s nose, preventing ingestion or grooming. It also reduces the amount of cigarette smoke required for exposures, due to the smaller nose-only conduits. As the subjects are restrained, they do not have access to water and food and stress associated with the restraint limits exposures to 30-60 minutes for animal welfare considerations. Therefore, models utilising this method may require multiple exposure sessions per day.

Although there are various examples of CS exposure protocols in the literature a chronic exposure (i.e. 5 days/week for up to six months), is often required for emphysema to develop.

» Check out two examples Of Cigarette Smoke Exposure COPD model development & applications here «

FACTORS AFFECTING EMPHYSEMA DEVELOPMENT AND MODEL STANDARDIZATION

The factors influencing the CS exposure emphysema model include animal strain and sex, smoke concentration and duration of exposure. Several experimental factors can influence experiment standardization and reproducibility:

  • Duration of exposure: A detailed explanation of the exposure protocol should be reported, including number of exposure sessions per day, duration of exposure sessions, number of cigarettes used per session, TPM values, total length of experiment/study (usually weeks or months).
  • Measurement of Total Particulate Matter (TPM): Total Particulate Matter (TPM) gives a measure of smoke concentration. It is usually monitored during each exposure session and is reported in mg/L, with typical values ranging from 75 to 600 mg/L. Different TPM values have been shown to induce different physiological responses from exposed subjects, and is thus are of critical value to report when developing emphysema models.
  • Type of cigarettes: Most published studies used the Kentucky reference cigarettes 3RF4. Recently, these have been replaced with the new certified 1R6F cigarettes. These reference cigarettes are produced to provide consistent tar and nicotine contents.
  • Puffing standards: Puffing standards dictate a single puff’s volume, duration, maximum peak flow and minimum required interval between puffs. The most common standards used in CS-exposure studies are the ISO standard puff (35 mL puff / 60 s interval) and the Health Canada Intense (HCI) profile (55 mL puff / 30s).
Elastase Cigarette Smoke
Benefits
  • Fast, short duration à causes significant and rapid changes in lung
  • Low-cost rodent model
  • Simple exposure protocol, less labour intensive
  • Pulmonary changes can last up to 6 months à useful model for studies on tissue/lung mechanisms of repair
  • Dose dependant – severity of lung injury (inflammation, oxidative stress, apoptosis, body weight loss, reduced endurance) can be modulated by enzyme dose titration
  • Considered gold-standard, more accurate mimic of human exposure à highest relevance to human COPD
  • Acute exposures à allow investigation of molecular mechanisms responsible for initiation & propagation of lung/systemic injury”
  • Diversity of exposures possible à side-stream smoke, main-stream smoke or a mixture of both
  • Automated systems available
Limitations
  • Artificial nature of enzyme exposure
  • Sudden onset of severe inflammatory injury à does not model human COPD
  • Limited initiation of pathways of lung injury & systemic involvement
  • Dependant on several factors à strain, PPE dose at each instillation, number of PPE challenges
  • Time dependent
  • Cumbersome, long duration experiments à chronic exposure daily for 6 months
  • Diversity of human smoking patterns à Difficult to establish single experimental protocol
  • Animal restrained – deprivation of food & water, stress

Other Models of COPD

Animal Models for COPD

Genetic models

COPD is a heterogenous disease and recent GWAS studies have identified several genes that may contribute to disease initiation and/or progression. Genetic models are thus useful to investigate the role of particular genes for susceptibility to COPD development and pathogenesis.

Functional studies have evaluated the role of various genes in lung function, and disease development and progression. Some genes have been shown to alter susceptibility to environmental exposure-induced COPD, while others result in spontaneous COPD development.

Mice are currently the most widely used species to manipulate gene expression. Most studies use whole-body knockout animal models. There are two major approaches for targeted gene manipulation:

  • Gain-of-function: gene overexpression in transgenic mice or expression of human gene (or variant)
  • Loss-of-function: loss of gene expression by targeted direct or chemical mutagenesis

 

Examples
  • Itgb6−/− or klotho−/− mice: results in spontaneous COPD development as animals age
  • Mice expressing MMP1 human gene: results in COPD development without environmental exposures
  • Mice deficient for Nrf2, Ptp1b, Gpx1 or p53: CS inhalation or PPE instillation in these animals exaggerates COPD-like changes and creates COPD phenotype. In this case, synergy between gene manipulation and exposure is required to observe lung changes causing disease
  • Mmp12−/−, Cav1−/−, iNOS−/−, Tnfr−/− and Mrp1−/−Mdr1a−/−Mdr1b−/− mice: confers protection against CS exposure or PPE induced COPD

 

Models of bronchitis

Chronic bronchitis is one of the two main phenotypes of COPD. Various studies have worked on developing animal models of chronic bronchitis. The induction is done by means of exposure to different noxious/toxic inhalants, most commonly:

  • sulfur dioxide (SO2): induces chronic injury and repair in epithelial cells, in rats, and ferrets; following daily exposures at high gas concentrations (200-700 ppm for 4-8 weeks). Changes include neutrophilic inflammation, mucus production, mucus cell metaplasia and damage of ciliated epithelial.
  • nitrogen dioxide (NO2): can cause serious pulmonary injuries leading to animal death, including pulmonary edema, hemorrhage, and pleural effusion. Injury is dependant on concentration, exposure duration and species susceptibility. Non-lethal exposures lead to cilia injury, hypertrophy of bronchial epithelium and a type of II pneumocyte hyperplasia in rats, hamsters, and mice.
  • ozone O3 : a powerful oxidant and toxic air pollutant that has been shown to cause COPD-like lesions in just 6 weeks, resembling that of chronically CS-exposed mice (6-8 months). Exposure leads to emphysema-like alveolar airspace enlargement, chronic lung inflammation and enhanced levels of pro-inflammatory cytokines.

Species and Strains

Species and strains are important factors to consider when developing COPD animal models, as each will respond differently to injury induced by either elastase or CS exposure, with differences in lung development and maturation. Learn more here.

copd-featured-resource